十二指肠-空肠旁路支架与腹腔镜袖状胃切除术在肥胖合并MASLD患者中的短期疗效与围手术期安全性:回顾性队列研究
该回顾性队列研究纳入96例接受减重干预的肥胖合并MASLD患者,其中DJBS组31例、LSG组65例。结果显示LSG组3个月绝对体重下降大于DJBS组,但DJBS组在LDL-C、空腹血糖和糖化血红蛋白改善上更优,且Clavien-Dindo I级不良事件更少。两组总体术后并发症率无显著差异。
要点
- LSG组3个月绝对体重下降大于DJBS组(17.66±6.36 kg vs 8.29±6.47 kg,p<0.001)。
- DJBS组在LDL-C、空腹血糖和糖化血红蛋白降低方面优于LSG组。
- 两组总体并发症率相似,但DJBS组Clavien-Dindo I级不良事件更少(p=0.007)。
核心结论
- DJBS可带来中等程度的短期体重下降且围手术期安全性更好,而LSG减重效果更显著。
- 两种干预对肝脏相关生化指标的短期改变相当。
研究设计与样本
- 回顾性队列研究,共纳入96例接受减重干预的肥胖合并MASLD患者。
- 按手术方式分组:DJBS组31例,LSG组65例。
- DJBS组平均年龄38.23±9.93岁,女性19例(61.3%)。
主要发现
- 3个月绝对体重下降:DJBS组8.29±6.47 kg,LSG组17.66±6.36 kg,差异有统计学意义(p<0.001)。
- DJBS组在LDL-C、空腹血糖和糖化血红蛋白降低方面优于LSG组,其他代谢指标结果相当。
- 总体术后并发症率DJBS组8.99% vs LSG组18.85%,p=0.424。
- Clavien-Dindo I级不良事件在DJBS组更少见(p=0.007)。
- 多重线性回归显示手术方式(LSG vs DJBS)(β=8.458,p<0.001)和术前腰围(β=0.078,p=0.038)是与术后体重下降相关的独立因素。
临床怎么用
- 对于肥胖合并MASLD患者,若优先考虑围手术期安全性及代谢指标改善,DJBS可作为短期选择。
- 若以最大化短期体重下降为目标,LSG可能更合适。
- 术前腰围较大的患者术后体重下降可能更明显,可作为评估参考。
局限性
- 回顾性研究设计可能存在选择偏倚。
- 样本量较小(共96例),DJBS组仅31例。
- 仅报告短期(3个月)结局,缺乏长期随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Aims Obesity is a critical risk factor for progression of metabolic dysfunction-associated steatotic liver disease (MASLD). Laparoscopic sleeve gastrectomy (LSG) and duodenal-jejunal bypass stent (DJBS) are two major weight-loss modalities, yet comparative evidence remains limited. Materials and Methods Patients receiving bariatric interventions were retrospectively analysed. The patients were grouped according to different surgical methods, and the demographic data, anthropological characteristics, treatment plans and prognosis of the patients were compared and analysed. Results A total of 96 patients were included in this study, with 31 patients in the DJBS group and 65 patients in the LSG group. The mean age of the DJBS group was 38.23 ± 9.93 years, and 19 patients (61.3%) were female. The absolute weight loss at 3 months was 8.29 ± 6.47 kg in the DJBS group and 17.66 ± 6.36 kg in the LSG group, with a statistically significant difference (p < 0.001). DJBS achieved superior reductions in LDL-C, fasting glucose and glycated haemoglobin and comparable outcomes for other metabolic markers. The overall post-procedural complication rate was similar between DJBS and LSG (8.99% vs. 18.85%, p = 0.424). Clavien-Dindo Grade I adverse events were less frequent in the DJBS group (p = 0.007). Multiple linear regression analysis demonstrated that surgical procedure (LSG vs. DJBS) (β = 8.458, p < 0.001) and preoperative waist circumference (β = 0.078, p = 0.038) were independent factors associated with post-procedural weight loss. Conclusions DJBS produces moderate short-term weight loss with better perioperative safety, while LSG achieves greater weight reduction. Both interventions were associated with comparable short-term changes in liver-related biochemical markers.
引用
- Diabetes, Obesity and Metabolism:Duodenal‐Jejunal Bypass Stent Versus Laparoscopic Sleeve Gastrectomy in Patients With Obesity and MASLD: Short‐Term Efficacy and Perioperative Safety in a Retrospective Cohort Study
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。